Abstract
Superior mesenteric venous thrombosis (SMVT) is responsible for 6% to 9% of mesenteric ischemia cases and 1 in 5000 to 15,000 hospital admissions. SMVT occurs in the setting of stasis, surgery, vessel injury, hypercoagulable states, malignancy, portal hypertension, and inflammatory disorders. While endovascular treatment is considered as one of the therapeutic modalities, there is a paucity of information regarding the outcomes. This study aims to evaluate the outcomes of SMVT following various endovascular intervention techniques.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
